LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 16.29 | 84.90 | 1097 | 766 | 1.4305 | 1.2387 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 17.99 | 84.90 | 442 | 898 | 0.4917 | 0.6236 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 17.99 | 84.90 | 1225 | 898 | 1.3627 | 1.1903 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 17.99 | 84.90 | 12 | 898 | 0.0133 | -0.4371 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 17.99 | 84.90 | 1171 | 898 | 1.3026 | 1.1615 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 19.69 | 84.90 | 1026 | 1239 | 0.8278 | 0.9046 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 19.69 | 84.90 | 1364 | 1239 | 1.1005 | 1.0501 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 19.69 | 84.90 | 21 | 1239 | 0.0169 | -0.3031 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 19.69 | 84.90 | 1242 | 1239 | 1.0021 | 1.0011 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 21.40 | 84.90 | 1297 | 1454 | 0.8916 | 0.9448 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 21.40 | 84.90 | 1527 | 1454 | 1.0497 | 1.0238 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 21.40 | 84.90 | 25 | 1454 | 0.0172 | -0.2579 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 21.40 | 84.90 | 1345 | 1454 | 0.9246 | 0.9621 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 23.10 | 84.90 | 1475 | 1616 | 0.9126 | 0.9574 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 23.10 | 84.90 | 1663 | 1616 | 1.0289 | 1.0135 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 23.10 | 84.90 | 33 | 1616 | 0.0204 | -0.1993 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 23.10 | 84.90 | 1465 | 1616 | 0.9064 | 0.9543 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 24.81 | 84.90 | 1647 | 1769 | 0.9308 | 0.9675 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 24.81 | 84.90 | 1822 | 1769 | 1.0297 | 1.0134 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 24.81 | 84.90 | 47 | 1769 | 0.0266 | -0.1262 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 24.81 | 84.90 | 1584 | 1769 | 0.8952 | 0.9501 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 26.51 | 84.90 | 1780 | 1923 | 0.9256 | 0.9659 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 26.51 | 84.90 | 1935 | 1923 | 1.0062 | 1.0027 | MN20160318_Q02 | C08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 26.51 | 84.90 | 63 | 1923 | 0.0328 | -0.0641 | MN20160318_Q02 | D15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0033333 | 26.51 | 84.90 | 1727 | 1923 | 0.8980 | 0.9528 | MN20160318_Q02 | D15 |